In an interview with OncLive at the 2017 State of the Science SummitTM on Treatment Options in Ovarian Cancer, Dr. Dmitriy Zamarin from MSK addressed the future potential of deploying combinations of immunotherapy treatments for gynecologic cancers. Read the full interview here.